ALS usually announces itself with something deceptively ordinary: a hand that fumbles with buttons, a foot that drags on a curb, or speech that starts to slur for no obvious reason. Because those early signs overlap with dozens of more common conditions, most people see an average of three doctors and wait close to a year before receiving a confirmed diagnosis.
What the First Signs Actually Look Like
About two-thirds of people with ALS first notice problems in a limb. The pattern varies. Some people describe a weakening grip that makes it hard to turn a key or open a jar. Others feel a heaviness in one leg that causes tripping or an awkward gait. Muscle twitching, called fasciculations, is common too, though twitching alone is extremely common in healthy people and almost never means ALS. What distinguishes ALS-related twitching is that it shows up alongside progressive weakness in the same area.
The remaining roughly one-third of people experience what clinicians call bulbar-onset ALS, meaning the disease starts in the muscles controlled by the brainstem. The earliest clue is often slurred or nasal-sounding speech, difficulty swallowing solid food, or hoarseness that worsens over weeks and months.1PubMed Central. Bulbar onset amyotrophic lateral sclerosis: A case report Facial weakness and tongue wasting can follow. People sometimes describe choking on water or noticing that their voice sounds “thick” before any limb weakness appears at all.
A much rarer presentation, accounting for fewer than three percent of cases, begins with breathing problems. Shortness of breath during exertion, difficulty breathing while lying flat, or unexplained morning headaches from nighttime carbon dioxide buildup can be the first signals. Some patients develop a forward-stooping posture or a head that drops forward, along with early weight loss, before limb weakness becomes obvious.2PubMed Central. Prognosis of amyotrophic lateral sclerosis with respiratory onset Respiratory-onset ALS is easily mistaken for heart or lung disease, and its prognosis tends to be worse than either the limb or bulbar forms.3PubMed. ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis
Why It Takes So Long to Get Diagnosed
A median diagnostic delay of about 11 to 12 months from the first symptom is consistently reported across multiple countries and centers.4PubMed Central. Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries That number hides a wide range: some people are diagnosed within a few months while others wait two years or more. Roughly half of all patients receive at least one wrong diagnosis before ALS is confirmed, and on average each person sees three different physicians along the way.5PubMed Central. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
One counterintuitive finding is that seeing a doctor early doesn’t necessarily shorten the time to diagnosis. A multicenter study found that people who sought medical attention sooner after symptom onset actually experienced a longer overall time to diagnosis, because ALS is extremely hard to pin down in its early stages.4PubMed Central. Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries The disease has to progress enough that a clear clinical picture emerges, and in the meantime, doctors reasonably investigate more common explanations first.
Bulbar-onset ALS tends to be diagnosed about four months faster than limb-onset ALS. The likely reason is that slurred speech and swallowing difficulty prompt earlier specialist referral, whereas limb weakness is more commonly chalked up to orthopedic or musculoskeletal problems.6PubMed Central. Diagnostic Delay in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis Comparing Time From Symptom Onset to Diagnosis in Bulbar-Onset Versus Limb-Onset Disease
The Wrong Diagnoses People Get First
ALS’s early symptoms mimic a frustratingly long list of other conditions. When weakness starts in the hand, carpal tunnel syndrome and cubital tunnel syndrome are common initial diagnoses. A survey of hand surgeons found that 11 percent of members had actually performed nerve decompression surgery on patients who were later diagnosed with ALS.7PubMed. Misdiagnosis in Amyotrophic Lateral Sclerosis That statistic is sobering. It means a meaningful number of people go through a surgical procedure for a condition they don’t have before the real problem is identified.
Other common misdiagnoses include cervical or lumbar spine disease, peripheral neuropathy, myasthenia gravis, and benign fasciculation syndrome. When the disease starts in the legs, orthopedic issues like a herniated disc or knee problems are often investigated first. When speech is affected, some patients are initially evaluated for a stroke. Each detour adds weeks or months to the diagnostic timeline.
What the Diagnostic Workup Involves
There is no single blood test or scan that confirms ALS. Diagnosis remains largely clinical, meaning it depends on a neurologist recognizing a pattern of both upper and lower motor neuron damage that spreads over time and cannot be explained by another disease. The process is partly about finding evidence of ALS and partly about ruling out everything else.
Upper motor neuron signs include exaggerated reflexes, muscle stiffness, and abnormal reflexes like the Babinski response. Identifying these signs is a cornerstone of ALS diagnosis, though they can be difficult to spot when muscles are already severely weakened.8PubMed Central. Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS Lower motor neuron signs include visible muscle wasting, fasciculations, and weakness.
Electromyography, commonly called EMG, is one of the most important tests. A needle electrode is inserted into muscles to measure their electrical activity. The test can detect denervation, the loss of nerve supply to muscle fibers, even before weakness is clinically obvious. Nerve conduction studies accompany EMG to help rule out treatable conditions like peripheral neuropathies or nerve entrapment.9PubMed Central. Electrodiagnosis in persons with amyotrophic lateral sclerosis
MRI scans of the brain and spinal cord are standard, not because they can diagnose ALS directly but because they can reveal conditions that mimic it, such as tumors, spinal cord compression, or multiple sclerosis. Blood work screens for autoimmune diseases, thyroid problems, and other metabolic causes of weakness. In some cases, a lumbar puncture is performed to analyze cerebrospinal fluid.
Who Waits Longer and Why
The diagnostic delay isn’t evenly distributed. Several factors push the timeline out. People over 60 are significantly more likely to face a long wait. In one cohort, the total time from first symptom to confirmed diagnosis was about 50 percent longer in people over 60 compared to younger patients.5PubMed Central. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) Older adults are more likely to have pre-existing conditions like arthritis or spinal stenosis that can mask or be blamed for new weakness.
Male patients with limb-onset ALS also tend to wait longer than average. A systematic review found that delays exceeding 12 months were roughly twice as common in spinal-onset cases and in men. Female patients, on the other hand, tended to receive earlier diagnoses, a finding partly explained by the higher proportion of bulbar-onset disease in women.10Journal of the Neurological Sciences. Diagnostic delay in amyotrophic lateral sclerosis: A systematic review People with sporadic ALS, meaning no known family history, also experienced about 46 percent longer diagnostic times than those with a family history of the disease, likely because a known family history puts ALS higher on the list of suspects from the start.5PubMed Central. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
Neurofilament Light Chain and the Push for a Blood Biomarker
One of the most promising developments in ALS diagnosis is the measurement of neurofilament light chain, a protein released into the blood and spinal fluid when nerve cells are damaged. In people with ALS, levels of this protein are dramatically elevated. One study found that blood levels in ALS patients averaged about 81 pg/mL compared to roughly 9 pg/mL in healthy controls.11PubMed Central. Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort Cerebrospinal fluid measurements can distinguish ALS patients from healthy controls with about 97 percent sensitivity and 95 percent specificity, while blood-based tests reach about 89 to 90 percent sensitivity.12PubMed Central. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
The catch is that neurofilament light chain isn’t specific to ALS. It rises in other neurodegenerative diseases, in traumatic brain injury, and in some inflammatory conditions of the nervous system. So it works better as supporting evidence than as a standalone test. It’s also proving valuable for prognosis: higher levels at diagnosis predict a faster disease course and shorter survival.11PubMed Central. Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort For people caught in the limbo of an uncertain diagnosis, a very high neurofilament level can nudge the clinical picture toward ALS even when the physical exam is still ambiguous.
The Emotional Weight of the Diagnostic Limbo
People describe the months between first symptoms and diagnosis as some of the worst of the entire illness. In a qualitative study of ALS patients in China, participants described the waiting period in vivid terms. One person said, “This time of waiting really tortures people. Every second for me was like a year so long.” Another reported, “Every day I wait for the results is getting longer. I wish I knew.” A third described a four-month diagnostic journey and said the thing they dreaded most each day was seeing the doctor’s notes.13PubMed Central. Exploring amyotrophic lateral sclerosis patients’ experiences of psychological distress during the disease course in China: a qualitative study
When the diagnosis finally arrives, shock and disbelief are the dominant reactions. One patient said, “I was shocked and confused at the time of diagnosis, and I was struggling to come to terms with this unfortunate reality.”13PubMed Central. Exploring amyotrophic lateral sclerosis patients’ experiences of psychological distress during the disease course in China: a qualitative study This emotional burden is compounded by the fact that ALS can also cause cognitive and behavioral changes in some patients, which need to be distinguished from the psychological response to receiving a terminal diagnosis.14PubMed Central. The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers Apathy, impulsivity, or difficulty with planning might be mistaken for depression or denial when they are actually part of the disease itself.
Bulbar-Onset ALS and Its Link to Cognitive Changes
People whose disease begins with speech and swallowing problems may face an additional layer of complexity. Research suggests that bulbar-onset ALS may be more commonly associated with cognitive and language impairments than the limb-onset form. Post-mortem studies have found changes in Broca’s area and Wernicke’s area, brain regions involved in speech and language processing, exclusively in bulbar-onset cases.15PubMed Central. The neuropathological signature of bulbar-onset ALS: A systematic review Some bulbar-onset cases also showed unusual pathological features not found in spinal-onset patients, hinting that the two forms may not just be the same disease starting in different places but could involve partially distinct patterns of brain damage.
This matters practically because language difficulties in bulbar-onset ALS can be mistaken for simple mechanical speech problems. A speech-language pathologist might focus entirely on the physical aspects of articulation without recognizing that word-finding difficulties or sentence construction errors are part of the neurological picture. The overlap between motor speech problems and cognitive-linguistic problems makes assessment more complex and is an area of active research.
What Genetic Testing Reveals
About 90 to 95 percent of ALS cases are classified as sporadic, meaning the person has no known family history. But the genetics of ALS are turning out to be more complicated than that clean split suggests. In a large screening program of nearly 2,000 patients, the most commonly identified genetic variant was the C9orf72 hexanucleotide repeat expansion, found in 7 percent of those tested. SOD1 mutations, now significant because a targeted therapy called tofersen exists, were identified in about 1.8 percent. Among patients carrying SOD1 mutations, 68 percent reported no family history of ALS at all.16PubMed. SOD1 gene screening in ALS – frequency of mutations, patients’ attitudes to genetic information and transition to tofersen treatment in a multi-center program
That last finding is worth pausing on. It means that having no family history doesn’t rule out a genetic cause, and it’s increasingly recognized that genetic testing can have direct treatment implications. A Brazilian cohort study found pathogenic variants in about 20 percent of patients who underwent panel or exome sequencing, a number consistent with international data for mixed familial-sporadic groups.17PubMed Central. Genetic profile of motor neuron disease in a multiregional Brazilian cohort: an 18-year real-world experience in 1,911 patients The yield was highest in people with a clear family history but was still nearly 5 percent in those classified as sporadic. This has shifted thinking in the field: genetic screening is increasingly seen as worthwhile for anyone diagnosed with ALS, not just those with affected relatives.
What Is Actually Happening Inside Motor Neurons
In up to 97 percent of ALS cases, the central problem visible under a microscope is the buildup of a protein called TDP-43 in the wrong part of the cell.18PubMed Central. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD Normally, TDP-43 lives in the nucleus of a cell, where it helps manage RNA, the molecular instructions cells use to make proteins. In ALS, TDP-43 misfolds, clumps together in the cytoplasm outside the nucleus, and is depleted from the nucleus where it’s needed.19PubMed Central. TDP-43-The key to understanding amyotrophic lateral sclerosis
This creates a double hit. The cell loses the normal function of TDP-43 in the nucleus, and the misfolded clumps in the cytoplasm are themselves toxic. Worse, the misfolded protein can recruit normal TDP-43 molecules into the aggregates, accelerating the problem in a feed-forward loop.20Neurotherapeutics. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets Understanding this mechanism matters beyond academic interest because it suggests that therapies able to restore normal TDP-43 folding or clear misfolded protein early could potentially address both the loss-of-function and gain-of-toxicity sides of the disease.
Machine Learning and Voice Analysis
One avenue that could eventually shorten the diagnostic delay is the use of automated voice analysis. Subtle changes in speech, including shifts in pitch, rhythm, and articulation that are too slight for a human listener to reliably detect, can precede the point at which a clinician would diagnose bulbar involvement. A study developing machine learning models for detecting bulbar involvement in ALS patients reported accuracy as high as about 96 percent using support vector machines, and the researchers found that the model could improve on human diagnostic accuracy, which often misses early bulbar changes.21JMIR Medical Informatics. Detection of Bulbar Involvement in Patients With Amyotrophic Lateral Sclerosis by Machine Learning Voice Analysis: Diagnostic Decision Support Development Study This technology is still in research stages, but the idea is appealing: a simple voice recording analyzed by software could flag people for earlier neurological evaluation, particularly in primary care settings where ALS is rarely at the top of anyone’s differential diagnosis.
Spinal cord imaging is another field that has advanced considerably. While conventional MRI is used mainly to rule out other conditions, newer quantitative imaging techniques can now measure spinal cord atrophy and detect metabolic changes in the cord that reflect motor neuron loss.22PubMed Central. Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts-Novel Techniques Some of these methods have been applied to people who carry ALS-linked gene mutations but haven’t yet developed symptoms, raising the possibility of detecting the disease before clinical onset in genetically at-risk individuals.